Theratechnologies’ drug application is seeking approval for a formulation that is eight times stronger than the initial product. GSK Pushes First-in-Class Antibiotic for Uncomplicated UTI By March 26, ...

A new review highlights the pivotal role of LSD1 (lysine-specific demethylase 1) in regulating critical cellular processes and its implications for human diseases. This article sheds light on how post ...

A new review highlights the pivotal role of LSD1 (lysine-specific demethylase 1) in regulating critical cellular processes and its implications for human diseases. This article sheds light on how ...

Image Caption: The structure of LSD1. By expanding our understanding of LSD1 and its modifications, this research provides a foundation for developing novel therapeutic strategies, offering hope ...

The market was pleased with the recent earnings report from GSK plc (LON:GSK), despite the profit numbers being soft. However, we think the company is showing some signs that things are more ...

Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have gone elsewhere without tax incentives approved by local officials last year.

为探究 RBBP7 对乳腺癌（BCa）干性和转移的影响，研究发现 SE-RBBP7-LSD1 轴或为 BCa 治疗新靶点。 在全球范围内，乳腺癌（Breast Cancer，BCa）是严重威胁女性健康的 “头号杀手” 。它就像一个隐藏在暗处的恶魔，在女性群体中肆意肆虐，占据了所有女性恶性肿瘤的 30 ...

While a direct targeting of the partial loss-of-function or change in function observed in these factors is very difficult to imagine, recent data suggests that the inhibition of LSD1, an important ...

GSK (GSK) announced the US Food and Drug Administration, FDA, has accepted for review the Biologics License Application, BLA, for the use of depemokimab in two indications. The proposed ...

With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahead to a potential blockbuster premiere of its own. The British Big Pharma has filed depemokimab for FDA approval ...

Pfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion (DEI) webpage, becoming the latest Big Pharma after GSK (NYSE:GSK) to revise DEI initiatives amid the Trump ...

This month's cover highlights the article Natural variations of adolescent neurogenesis and anxiety predict the hierarchical status of adult inbred mice by Nicolas Toni, Thomas Larrieu and colleagues.